Skip to content

A multicenter clinical trial study of C/M dual biomarkers for liver cancers

A multicenter clinical trial study of C/M dual biomarkers for liver cancers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14005079
Enrollment
Unknown
Registered
2014-07-30
Start date
2013-03-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancers

Interventions

Gold Standard:
Index test:

Sponsors

The First Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 94 Years

Inclusion criteria

Inclusion criteria: Serum samples of HCC, consisting of different types and stages of liver cancers and with proportional distributions of positive samples in the low, median and high measurement values

Exclusion criteria

Exclusion criteria: Excluded samples that: 1) have microbial contamination; 2) are turbid with severe hemolysis (except used as the interference controls); 3) have incorrect clincal diagnosis.

Design outcomes

Primary

MeasureTime frame
C/M;

Countries

China

Contacts

Public ContactLihua Wu
wlh_wu@aliyun.com+86 571-87236560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026